A randomized double-blind phase II study evaluating the role of maintenance therapy with cabozantinib in high grade undifferentiated uterine sarcoma (HGUS) after stabilization or response to doxorubicin +/- ifosfamide following surgery or in metastatic first line treatment

I. L. Ray-Coquard; A. P. I. de Tos; C. Coens; M. Huizing; A. Casado Herraez; A. M. Westermann; E. Bompas; H. Earl; M. L. Hensley; A. Negrouk; N. Reed

doi:10.1093/annonc/mdw388.27

A randomized double-blind phase II study evaluating the role of maintenance therapy with cabozantinib in high grade undifferentiated uterine sarcoma (HGUS) after stabilization or response to doxorubicin +/- ifosfamide following surgery or in metastatic first line treatment

I. L. Ray-Coquard
, A. P. I. de Tos
, C. Coens
, M. Huizing
, A. Casado Herraez
, A. M. Westermann
, E. Bompas
, H. Earl
, M. L. Hensley
, A. Negrouk
, N. Reed

Research output: Contribution to journal › Article › Academic › peer-review

Original language	English
Pages (from-to)	vi492
Journal	Annals of oncology
Volume	27
DOIs	https://doi.org/10.1093/annonc/mdw388.27
Publication status	Published - 2016

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1093/annonc/mdw388.27

Cite this

Ray-Coquard, I. L., de Tos, A. P. I., Coens, C., Huizing, M., Herraez, A. C., Westermann, A. M., Bompas, E., Earl, H., Hensley, M. L., Negrouk, A., & Reed, N. (2016). A randomized double-blind phase II study evaluating the role of maintenance therapy with cabozantinib in high grade undifferentiated uterine sarcoma (HGUS) after stabilization or response to doxorubicin +/- ifosfamide following surgery or in metastatic first line treatment. Annals of oncology, 27, vi492. https://doi.org/10.1093/annonc/mdw388.27

Ray-Coquard, I. L. ; de Tos, A. P. I. ; Coens, C. et al. / A randomized double-blind phase II study evaluating the role of maintenance therapy with cabozantinib in high grade undifferentiated uterine sarcoma (HGUS) after stabilization or response to doxorubicin +/- ifosfamide following surgery or in metastatic first line treatment. In: Annals of oncology. 2016 ; Vol. 27. pp. vi492.

@article{d082c6cb1dca410dbacad9b3faa78af2,

title = "A randomized double-blind phase II study evaluating the role of maintenance therapy with cabozantinib in high grade undifferentiated uterine sarcoma (HGUS) after stabilization or response to doxorubicin +/- ifosfamide following surgery or in metastatic first line treatment",

author = "Ray-Coquard, \{I. L.\} and \{de Tos\}, \{A. P. I.\} and C. Coens and M. Huizing and Herraez, \{A. Casado\} and Westermann, \{A. M.\} and E. Bompas and H. Earl and Hensley, \{M. L.\} and A. Negrouk and N. Reed",

year = "2016",

doi = "10.1093/annonc/mdw388.27",

language = "English",

volume = "27",

pages = "vi492",

journal = "Annals of oncology",

issn = "0923-7534",

publisher = "Oxford University Press",

}

Ray-Coquard, IL, de Tos, API, Coens, C, Huizing, M, Herraez, AC, Westermann, AM, Bompas, E, Earl, H, Hensley, ML, Negrouk, A & Reed, N 2016, 'A randomized double-blind phase II study evaluating the role of maintenance therapy with cabozantinib in high grade undifferentiated uterine sarcoma (HGUS) after stabilization or response to doxorubicin +/- ifosfamide following surgery or in metastatic first line treatment', Annals of oncology, vol. 27, pp. vi492. https://doi.org/10.1093/annonc/mdw388.27

A randomized double-blind phase II study evaluating the role of maintenance therapy with cabozantinib in high grade undifferentiated uterine sarcoma (HGUS) after stabilization or response to doxorubicin +/- ifosfamide following surgery or in metastatic first line treatment. / Ray-Coquard, I. L.; de Tos, A. P. I.; Coens, C. et al.
In: Annals of oncology, Vol. 27, 2016, p. vi492.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - A randomized double-blind phase II study evaluating the role of maintenance therapy with cabozantinib in high grade undifferentiated uterine sarcoma (HGUS) after stabilization or response to doxorubicin +/- ifosfamide following surgery or in metastatic first line treatment

AU - Ray-Coquard, I. L.

AU - de Tos, A. P. I.

AU - Coens, C.

AU - Huizing, M.

AU - Herraez, A. Casado

AU - Westermann, A. M.

AU - Bompas, E.

AU - Earl, H.

AU - Hensley, M. L.

AU - Negrouk, A.

AU - Reed, N.

PY - 2016

Y1 - 2016

UR - https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85083629333&origin=inward

U2 - 10.1093/annonc/mdw388.27

DO - 10.1093/annonc/mdw388.27

M3 - Article

SN - 0923-7534

VL - 27

SP - vi492

JO - Annals of oncology

JF - Annals of oncology

ER -

Ray-Coquard IL, de Tos API, Coens C, Huizing M, Herraez AC, Westermann AM et al. A randomized double-blind phase II study evaluating the role of maintenance therapy with cabozantinib in high grade undifferentiated uterine sarcoma (HGUS) after stabilization or response to doxorubicin +/- ifosfamide following surgery or in metastatic first line treatment. Annals of oncology. 2016;27:vi492. doi: 10.1093/annonc/mdw388.27

A randomized double-blind phase II study evaluating the role of maintenance therapy with cabozantinib in high grade undifferentiated uterine sarcoma (HGUS) after stabilization or response to doxorubicin +/- ifosfamide following surgery or in metastatic first line treatment

UN SDGs

Access to Document

Other files and links

Cite this